Santa Rosa, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Montgomery Manor Convalescent Hospital Memorial Fund Inc, founded in 1983, is a small nonprofit in the Health Care sector that reported $454K in total revenue in fiscal year 2018. Expenses of $523K exceeded revenue, resulting in a 15% operating deficit.
Research, education and support for victims of Alzheimer's, their families, caregivers and the public
Biogen: Emerge Study - To study the efficacy and safety of an investgational medication called Aducanmab in people experiencing symptoms of early Alzheimer's disease. It is thought that Aducanumab...
Biogen: Emerge Study - To study the efficacy and safety of an investgational medication called Aducanmab in people experiencing symptoms of early Alzheimer's disease. It is thought that Aducanumab recognizded harmful amyloid plaques found in the brain of people with Alzheimer's disease. The study will determine if the investigational medication can remove the plaques and slow the progression of the disease.
Roche - Cread Crenezumab Protocol - This is a Phase III randomized, double-blinded, placebo-controlled sudy to evaluate the safety and efficacy of crenezumab (a fully humanized monoclonal antibody)...
Roche - Cread Crenezumab Protocol - This is a Phase III randomized, double-blinded, placebo-controlled sudy to evaluate the safety and efficacy of crenezumab (a fully humanized monoclonal antibody) in patients with initial to mild Alzheimer's disease. The study involves biweekly infusions of the drug to ascertain any change in their disease systems.
Lilly - Navigate - AD Study - Participated in an international investgational drug study to determine the possible effect of the study drug on the protein "Tau" build-up inside the brain. The study...
Lilly - Navigate - AD Study - Participated in an international investgational drug study to determine the possible effect of the study drug on the protein "Tau" build-up inside the brain. The study involves oral dosing of patient over a period of 52 weeks with a follow-up period to determine any effect on the buildup of Tau and other related Alzheimer's symptoms. The study also records and unwanted side effects.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2018 | 2017 | Change | |
|---|---|---|---|
| Revenue | $454,286 | $450,585 | +0.0% |
| Expenses | $523,002 | $301,115 | +0.7% |
| Net Income | $-68,716 | $149,470 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| John J Wotring | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| John L Wotring | President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Monika Moseley | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2018 | $454,286 | $523,002 | $34,358 | $-68,716 |
Compare Montgomery Manor Convalescent Hospital Memorial Fund Inc with other nonprofits in California and across the country.